IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance

被引:365
作者
Mumm, John B. [1 ]
Emmerich, Jan [1 ]
Zhang, Xueqing [1 ]
Chan, Ivan [1 ]
Wu, Lingling [1 ]
Mauze, Smita [1 ]
Blaisdell, Steven [2 ]
Basham, Beth [1 ]
Dai, Jie [1 ]
Grein, Jeff [1 ]
Sheppard, Catherine [1 ]
Hong, Kyu [1 ]
Cutler, Collette [2 ]
Turner, Scott [1 ]
LaFace, Drake [1 ]
Kleinschek, Melanie [1 ]
Judo, Michael [1 ]
Ayanoglu, Gulesi [1 ]
Langowski, John [1 ]
Gu, Danling [1 ]
Paporello, Brittany [2 ]
Murphy, Erin [1 ]
Sriram, Venkataraman [1 ]
Naravula, Saraswathi [1 ]
Desai, Bela [1 ]
Medicherla, Satya [1 ]
Seghezzi, Wolfgang [1 ]
McClanahan, Terrill [1 ]
Cannon-Carlson, Susan [2 ]
Beebe, Amy M. [1 ]
Oft, Martin [1 ]
机构
[1] Merck Res Labs, Palo Alto, CA 94301 USA
[2] Merck Res Labs, Biotechnol Dev, Union, NJ 07083 USA
关键词
EFFECTOR T-CELLS; INTERLEUKIN-10; CANCER; MELANOMA; INDUCTION; PROMOTES; BREAST; HOST;
D O I
10.1016/j.ccr.2011.11.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor immune surveillance and cancer immunotherapies are thought to depend on the intratumoral infiltration of activated CD8(+) T cells. Intratumoral CD8(+) T cells are rare and lack activity. IL-10 is thought to contribute to the underlying immune suppressive microenvironment. Defying those expectations we demonstrate that IL-10 induces several essential mechanisms for effective antitumor immune surveillance: infiltration and activation of intratumoral tumor-specific cytotoxic CD8(+) T cells, expression of the Th1 cytokine interferon-gamma (IFN gamma) and granzymes in CD8(+) T cells, and intratumoral antigen presentation molecules. Consequently, tumor immune surveillance is weakened in mice deficient for IL-10 whereas transgenic overexpression of IL-10 protects mice from carcinogenesis. Treatment with pegylated IL-10 restores tumor-specific intratumoral CD8(+) T cell function and controls tumor growth.
引用
收藏
页码:781 / 796
页数:16
相关论文
共 43 条
[11]   Type, density, and location of immune cells within human colorectal tumors predict clinical outcome [J].
Galon, Jerom ;
Costes, Anne ;
Sanchez-Cabo, Fatima ;
Kirilovsky, Amos ;
Mlecnik, Bernhard ;
Lagorce-Pages, Christine ;
Tosolini, Marie ;
Camus, Matthieu ;
Berger, Anne ;
Wind, Philippe ;
Zinzindohoue, Franck ;
Bruneval, Patrick ;
Cugnenc, Paul-Henri ;
Trajanoski, Zlatko ;
Fridman, Wolf-Herman ;
Pages, Franck .
SCIENCE, 2006, 313 (5795) :1960-1964
[12]  
Groux H, 1999, J IMMUNOL, V162, P1723
[13]  
Groux H, 1998, J IMMUNOL, V160, P3188
[14]   Antigen-specific immunotherapy and cancer vaccines [J].
Jäger, E ;
Jäger, D ;
Knuth, A .
INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (06) :817-820
[15]   Priming in the presence of IL-10 results in direct enhancement of CD8+ T cell primary responses and inhibition of secondary responses [J].
Kang, SS ;
Allen, PM .
JOURNAL OF IMMUNOLOGY, 2005, 174 (09) :5382-5389
[16]   T-CELL-MEDIATED CYTO-TOXICITY AGAINST AUTOLOGOUS MALIGNANT-MELANOMA - ANALYSIS WITH INTERLEUKIN 2-DEPENDENT T-CELL CULTURES [J].
KNUTH, A ;
DANOWSKI, B ;
OETTGEN, HF ;
OLD, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (11) :3511-3515
[17]   INTERLEUKIN-10-DEFICIENT MICE DEVELOP CHRONIC ENTEROCOLITIS [J].
KUHN, R ;
LOHLER, J ;
RENNICK, D ;
RAJEWSKY, K ;
MULLER, W .
CELL, 1993, 75 (02) :263-274
[18]   Swords into plowshares: IL-23 repurposes tumor immune surveillance [J].
Langowski, John L. ;
Kastelein, Robert A. ;
Oft, Martin .
TRENDS IN IMMUNOLOGY, 2007, 28 (05) :207-212
[19]   IL-23 promotes tumour incidence and growth [J].
Langowski, John L. ;
Zhang, Xueqing ;
Wu, Lingling ;
Mattson, Jeanine D. ;
Chen, Taiying ;
Smith, Kathy ;
Basham, Beth ;
McClanahan, Terrill ;
Kastelein, Robert A. ;
Oft, Martin .
NATURE, 2006, 442 (7101) :461-465
[20]   Proinflammatory effects of IL-10 during human endotoxemia [J].
Lauw, FN ;
Pajkrt, D ;
Hack, CE ;
Kurimoto, M ;
van Deventer, SJH ;
van der Poll, T .
JOURNAL OF IMMUNOLOGY, 2000, 165 (05) :2783-2789